Another study showed that, in similar-staged bladder UC (pT2, pT3, or pT4), patients with more CD8+ TILs within the tumor had better OS (P < 0.018) than patients with fewer CD8+ TILs (Sharma et al., 2007). This evidence concerns the gene CD8A and neoplasm.